Alle verbonden artikelen

Nutrition education in medical schools (NEMS). An ESPEN position paper.

Auteurs : Cuerda C, Muscaritoli M, Donini LM, Baqué P, Barazzoni R, Gaudio E, Jezek D, Krznaric Z, Pirlich M, Schetgen M, Schneider S, Vargas JA, Van Gossum A
Jaar : 2020
Journal : Clin Nutr
Volume : 39
Pagina's : 2938-2939

Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer.

Auteurs : Anciaux M, Demetter P, de Wind R, Gomez Galdon M, Vande Velde S, Lens G, Craciun L, Deleruelle A, Larsimont D, Lenaerts T, Sclafani F, Deleporte A, Donckier V, Hendlisz A, Vandeputte C
Jaar : 2020
Journal : BMJ Open Gastroenterol
Volume : 7

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. <i>

Auteurs : Krayem M, Aftimos P, Najem A, Hooven TVD, Berg AVD, Hovestad-Bijl L, Wijn R, Hilhorst R, Ruijtenbeek R, Sabbah M, Kerger J, Awada A, Journe F, Ghanem G
Jaar : 2020
Journal : Cancers (Basel)
Volume : 12

Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.

Auteurs : Venet D, Fimereli D, Rothé F, Boeckx B, Maetens M, Majjaj S, Rouas G, Capra M, Bonizzi G, Contaldo F, Galant C, Piccart-Gebhart M, Pruneri G, Larsimont D, Lambrechts D, Desmedt C, Sotiriou C
Jaar : 2020
Journal : EBioMedicine
Volume : 56
Pagina's : 102793

Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial.

Auteurs : Abi Jaoude J, de Azambuja E, Makki M, Tamim H, Tfayli A, Geara F, Piccart-Gebhart M, Poortmans P, Zeidan YH
Jaar : 2020
Journal : Int J Radiat Oncol Biol Phys
Volume : 106
Pagina's : 503-510

Oncology care: keep it going, Learn – Improve – Act (white paper BE, IPSEN, ALL-BE-000191- Oct 2020)

Auteurs : Awada A, Ameye F, Bangma CH, Bloemendal H, van Damme J, Gennigens C, de Herder W, Lybaert W, De Meerleer G, Peeters M, Romijn JA, Rottey S, Sedelaar JP, Seront E, Stouthard JM, Suelmann B, Tuytten T, Valk G, De Vries S, Willemse P
Jaar : 2020
Journal : IPSEN
Volume : -
Pagina's : -

Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> Mutations.

Auteurs : Lambertini M, Ameye L, Hamy AS, Zingarello A, Poorvu PD, Carrasco E, Grinshpun A, Han S, Rousset-Jablonski C, Ferrari A, Paluch-Shimon S, Cortesi L, Senechal C, Miolo G, Pogoda K, Pérez-Fidalgo JA, De Marchis L, Ponzone R, Livraghi L, Estevez-Diz MDP, Villarreal-Garza C, Dieci MV, Clatot F, Berlière M, Graffeo R, Teixeira L, Córdoba O, Sonnenblick A, Luna Pais H, Ignatiadis M, Paesmans M, Partridge AH, Caron O, Saule C, Del Mastro L, Peccatori FA, Azim HA Jr
Jaar : 2020
Journal : J Clin Oncol
Volume : 38
Pagina's : 3012-3023

ESPEN guideline on home parenteral nutrition.

Auteurs : Pironi L, Boeykens K, Bozzetti F, Joly F, Klek S, Lal S, Lichota M, Mühlebach S, Van Gossum A, Wanten G, Wheatley C, Bischoff SC
Jaar : 2020
Journal : Clin Nutr
Volume : 39
Pagina's : 1645-1666

Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.

Auteurs : Lucidi V, Bohlok A, Liberale G, Bez M, Germanova D, Bouazza F, Demetter P, Larsimont D, Aftimos P, Smoll NR, Donckier V
Jaar : 2020
Journal : Eur J Surg Oncol
Volume : 46
Pagina's : 229-234

Clinical management of first-line advanced triple-negative breast cancer patients

Auteurs : Rediti M, Punie K, de Azambuja E, Naert E, Taylor D, Duhoux FP, Denys H, Awada A, Wildiers H, Ignatiadis M
Jaar : 2020
Journal : Belgian J Medical Oncology
Volume : 14(7)
Pagina's : 333-338

De-intensifying Radiation Therapy in HER-2 Positive Breast Cancer: To Boost or Not to Boost?

Auteurs : Abi Jaoude J, Kayali M, de Azambuja E, Makki M, Tamim H, Tfayli A, El Saghir N, Geara F, Piccart-Gebhart M, Poortmans P, Zeidan YH
Jaar : 2020
Journal : Int J Radiat Oncol Biol Phys
Volume : 108
Pagina's : 1040-1046

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

Auteurs : Bouchart C, Navez J, Closset J, Hendlisz A, Van Gestel D, Moretti L, Van Laethem JL
Jaar : 2020
Journal : Ther Adv Med Oncol
Volume : 12
Pagina's : 1758835920936093

Digital analysis of distant and cancer-associated mammary adipocytes.

Auteurs : Isnaldi E, Richard F, De Schepper M, Vincent D, Leduc S, Maetens M, Geukens T, Floris G, Rouas G, Cardoso F, Sotiriou C, Zoppoli G, Larsimont D, Biganzoli E, Desmedt C
Jaar : 2020
Journal : Breast
Volume : 54
Pagina's : 179-186

Use of granulocyte-colony stimulating factors in older patients: a review of recently published data.

Auteurs : Klastersky JA, Dal Lago L, Lalami Y
Jaar : 2020
Journal : Curr Opin Oncol

Nécessité d’un plan national de santé pour les patients oncologiques pour éviter une vague de victimes collatérales du Covid-19

Auteurs : Donckier V, Awada A
Jaar : 2020
Journal : Onco-Hémato
Volume : 14(2)
Pagina's : 3

Fat density is a novel prognostic marker in patients with esophageal cancer.

Auteurs : Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C
Jaar : 2020
Journal : Clin Nutr ESPEN
Volume : 39
Pagina's : 124-130

Publisher Correction: The adenosine pathway in immuno-oncology.

Auteurs : Allard B, Allard D, Buisseret L, Stagg J
Jaar : 2020
Journal : Nat Rev Clin Oncol
Volume : 17
Pagina's : 650

Treatment algorithm in patients with ovarian cancer.

Auteurs : Vergote I, Denys H, De Greve J, Gennigens C, Van de Vijver K, Kerger J, Vuylsteke P, Baurain JF
Jaar : 2020
Journal : Facts Views Vis Obgyn
Volume : 12
Pagina's : 227-239

Effect of the COVID-19 pandemic on cancer treatment and research.

Auteurs : Saini KS, de Las Heras B, de Castro J, Venkitaraman R, Poelman M, Srinivasan G, Saini ML, Verma S, Leone M, Aftimos P, Curigliano G
Jaar : 2020
Journal : Lancet Haematol
Volume : 7
Pagina's : e432-e435

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

Auteurs : de Azambuja E, Ponde N, Procter M, Rastogi P, Cecchini RS, Lambertini M, Ballman K, Aspitia AM, Zardavas D, Roca L, Gelber Rd, Piccart-Gebhart M, Suter T
Jaar : 2020
Journal : Breast Cancer Res Treat
Volume : 179
Pagina's : 161-171